Literature DB >> 32274659

Metabolite profiling of whiteleg shrimp Litopenaeus vannamei from super-intensive culture in closed aquaculture systems: a recirculating aquaculture system and a hybrid zero water discharge-recirculating aquaculture system.

Gede Suantika1, Magdalena Lenny Situmorang2, Felicia Irene Saputra3, Safira Latifa Erlangga Putri4, Sastia Prama Putri4, Pingkan Aditiawati1, Eiichiro Fukusaki4.   

Abstract

INTRODUCTION: The production of the whiteleg shrimp Litopenaeus vannamei now accounts for approximately 75% of the total shrimp production in Indonesia. The techniques used to produce whiteleg shrimp in Indonesia are still dominated by conventional rearing strategies using open-pond systems, which often contribute to unpredictable culture performance and weak sustainability. Alternative production strategies of closed aquaculture systems, including the recirculating aquaculture system (RAS) and hybrid zero water discharge-recirculating aquaculture system (hybrid system), have been developed and implemented for higher productivity, stability and sustainability of whiteleg shrimp grow-out production in Indonesia. Despite the positive aspects of the application of closed aquaculture systems in shrimp aquaculture, the differences in the characteristics of shrimp grown in closed RAS and hybrid systems compared to open-pond systems remain unclear.
OBJECTIVE: This study aims to investigate the differences in the metabolite profiles of shrimp grown in intensive closed aquaculture systems, including an RAS and hybrid system, compared to those of shrimp grown in a semi-intensive, open, earthen pond system by means of non-targeted GC-MS metabolite profiling.
METHODS: Shrimp cultured in the closed systems (RAS and hybrid system) and an open system (pond) were harvested and subjected to GC-MS non-targeted metabolomics analysis. A total of 112 metabolites were annotated from shrimp samples and subjected to principal component analysis (PCA).
RESULTS: The metabolites annotated from GC-MS mainly included organic compounds, proteinogenic and non-proteinogenic amino acids, sugars, nucleosides and fatty acids. The results of principal component analysis showed several metabolites with high variable importance in projection (VIP) scores, including shikimic acid, β-alanine, uric acid, hypoxanthine, inosine, homocysteine, methionine, phenylalanine, tryptophan and lysine, as the main metabolites differentiating the shrimp grown in the three production systems.
CONCLUSION: Our findings showed that shrimp cultured in different aquaculture systems exhibited distinct metabolite profiles, and the metabolites showing high VIP scores, including shikimic acid, β-alanine, uric acid, hypoxanthine, inosine, homocysteine, methionine, phenylalanine, tryptophan and lysine, may serve as candidate markers to indicate the differences in shrimp from different production systems.

Entities:  

Keywords:  Gas chromatography-mass spectrometry; Hybrid system; Metabolomics; Open system; Recirculating aquaculture system; Shrimp

Mesh:

Substances:

Year:  2020        PMID: 32274659     DOI: 10.1007/s11306-020-01675-1

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  12 in total

Review 1.  Current metabolomics: practical applications.

Authors:  Sastia P Putri; Yasumune Nakayama; Fumio Matsuda; Takato Uchikata; Shizu Kobayashi; Atsuki Matsubara; Eiichiro Fukusaki
Journal:  J Biosci Bioeng       Date:  2013-01-29       Impact factor: 2.894

Review 2.  Current metabolomics: technological advances.

Authors:  Sastia P Putri; Shinya Yamamoto; Hiroshi Tsugawa; Eiichiro Fukusaki
Journal:  J Biosci Bioeng       Date:  2013-03-07       Impact factor: 2.894

3.  Anti-inflammatory, analgesic and antioxidant activities of 3,4-oxo-isopropylidene-shikimic acid.

Authors:  Jin-Yao Sun; Cui-Yu You; Kai Dong; Hai-Sheng You; Jian-Feng Xing
Journal:  Pharm Biol       Date:  2016-03-24       Impact factor: 3.503

4.  Crowding of white shrimp Litopenaeus vananmei depresses their immunity to and resistance against Vibrio alginolyticus and white spot syndrome virus.

Authors:  Yong-Chin Lin; Jiann-Chu Chen; Yu-Yuan Chen; Su-Tuen Yeh; Li-Li Chen; Chien-Lun Huang; Jen-Fang Hsieh; Chang-Che Li
Journal:  Fish Shellfish Immunol       Date:  2015-02-17       Impact factor: 4.581

5.  Comparative study of the key enzymes and biochemical substances involved in the energy metabolism of Pacific white shrimp, Litopenaeus vannamei, with different ammonia-N tolerances.

Authors:  Hongwei Shan; Zexing Geng; Shen Ma; Teng Wang
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2019-04-04       Impact factor: 3.228

6.  Immunomodulatory activity of shikimic acid and quercitin in comparison with oseltamivir (Tamiflu) in an in vitro model.

Authors:  A A E Bertelli; C Mannari; S Santi; C Filippi; M Migliori; L Giovannini
Journal:  J Med Virol       Date:  2008-04       Impact factor: 2.327

7.  Metabolic product response profiles of Cherax quadricarinatus towards white spot syndrome virus infection.

Authors:  Weiwei Fan; Yangfang Ye; Zhen Chen; Yina Shao; Xiaolu Xie; Weiwei Zhang; Hai-Peng Liu; Chenghua Li
Journal:  Dev Comp Immunol       Date:  2016-04-08       Impact factor: 3.636

8.  Physiological Responses of Pacific White Shrimp Litopenaeus vannamei to Temperature Fluctuation in Low-Salinity Water.

Authors:  Zhenlu Wang; Yuexin Qu; Muting Yan; Junyi Li; Jixing Zou; Lanfen Fan
Journal:  Front Physiol       Date:  2019-08-13       Impact factor: 4.566

9.  Antibacterial Activity of Shikimic Acid from Pine Needles of Cedrus deodara against Staphylococcus aureus through Damage to Cell Membrane.

Authors:  Jinrong Bai; Yanping Wu; Xiaoyan Liu; Kai Zhong; Yina Huang; Hong Gao
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

Review 10.  Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.

Authors:  Marta Fumagalli; Davide Lecca; Maria P Abbracchio; Stefania Ceruti
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.